Cinctive Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Cinctive Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-22,281	Closed	-$7.05M	–	533
2023 Q4	$7.05M	Buy	+22,281	New	+$4.33M	0.47%	66

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Cinctive Capital Management's KRTX Position: Q1 2024 in Review

Cinctive Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 22,281 shares — an estimated $7.05M sold.

Cinctive Capital Management first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $7.05M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Cinctive Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Cinctive Capital Management sold 22,281 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $7.05M.
Cinctive Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Cinctive Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $7.05M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Cinctive Capital Management's 13F filing for Q1 2024, filed 15 May 2024.